Analysis-Texas abortion pill ruling could disrupt U.S. drug oversight - Stock market news
WASHINGTON (Reuters) - A federal judge in Texas could soon order the U.S. Food and Drug Administration to withdraw its approval of abortion pill mifepristone, a move that if allowed to stand could severely undermine the agency, health policy and legal experts said. | 06:04am